<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: We aimed to characterize electrophysiological properties of pulmonary veins (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e>) in patients with <z:e sem="disease" ids="C0043202" disease_type="Disease or Syndrome" abbrv="wpw">Wolff-Parkinson-White (WPW) syndrome</z:e> and <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF), and to compare them to those in patients with WPW without AF </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: A total of 31 patients (mean age 40 ± 15 years, 23 males) with WPW were recruited: 16 patients with (AF group) and 15 without (controls) a history of AF </plain></SENT>
<SENT sid="2" pm="."><plain>The basic electrophysiological (EPS) and echocardiographic data were not different between the 2 groups </plain></SENT>
<SENT sid="3" pm="."><plain>Effective refractory periods (ERPs) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e> were significantly shorter in the AF group compared to controls: left superior (LS) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> ERP 185±29 versus 230 ± 24 ms, P = 0.001; left inferior <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> ERP 198 ± 25 versus 219 ± 26 ms, P = 0.04; right superior (RS) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> ERP 207 ± 25 versus 236 ± 19 ms, P = 0.001; right inferior <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> ERP 208 ± 30 versus 240 ± 19 ms, P = 0.003 </plain></SENT>
<SENT sid="4" pm="."><plain>Maximal veno-atrial conduction delay (i.e., the maximal prolongation of interval from stimulus delivered at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> ostia to proximal coronary sinus after extrastimulus compared to the basic drive cycle) was longer in the AF group when pacing from LSPV (69.3 ± 37.9 vs 32.6 ± 16.1 ms, P = 0.01) and RSPV (74.1 ± 25.9 vs 50.2 ± 26.5 ms, P = 0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>During EPS, AF was induced more often in the AF group (n = 7) compared to controls (n = 1; P = 0.04) </plain></SENT>
<SENT sid="6" pm="."><plain>Follow-up revealed that AF recurred in 3 patients in the AF group and none of the controls </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Patients with <z:e sem="disease" ids="C0043202" disease_type="Disease or Syndrome" abbrv="wpw">WPW syndrome</z:e> and AF have shorter ERPs of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e> and greater maximal veno-atrial conduction delay compared to patients with WPW without AF </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest a potential role of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e> in the development of AF in patients with WPW </plain></SENT>
</text></document>